September 10. 2020

AstraZeneca

I stated on this site and the social networking website Twitter in time stamped items the rushed coronavirus vaccines currently in production pose health risks (see time stamped items below that I wrote beginning in April of this year).

This week I was proven right. AstraZeneca has paused a phase 3 clinical trial of their coronavirus vaccine due to a participant becoming "seriously ill." The participant that became ill has been hospitalized and not much information is available on their condition.

America, Britain, Canada, Germany, China and Russia have all been working on vaccines. However, Dr. Anthony Fauci stated there will not be a coronavirus vaccine this year. The World Health Organization expressed they are not of the belief there will be a coronavirus vaccine this year.

Several prominent scientists are casting doubt on the Russian government's claims they have produced a working vaccine. Russian President Vladimir Putin has made statements regarding his government's vaccine being administered to Russians, even his family members, and he states it works. However, Putin has not released any scientific data on his government's vaccine for peer review or any form of scientific evaluation.

My time stamped tweets on that have been proven correct on the subject:

STORY SOURCE

 COVID-19 vaccine trial halted after participant becomes seriously ill

Published 1 day ago - ATLANTA - The drug giant AstraZeneca has temporarily shut down its coronavirus vaccine trial, after a British volunteer in the study became seriously ill. A company spokesperson called the pause "routine," and said it is something that needs to happen anytime a participant in a clinical trial suffers an unexplained severe adverse reaction...

AstraZeneca has not revealed what sort of medical complication the trial participant experienced. Until more is known about this case, Dr. del Rio, whose hospital system is testing the Moderna mRNA vaccine, another leading COVID-19 vaccine candidate, says it makes sense for AstraZeneca to halt its research to investigate the issue...

https://www.fox5atlanta.com

Fauci says a coronavirus vaccine is ‘unlikely’ by U.S. election

Published Tue, Sep 8 20201:49 PM EDTUpdated Tue, Sep 8 20202:53 PM EDT - The CDC has asked states to ready facilities to distribute a coronavirus vaccine by Nov. 1. Dr. Anthony Fauci said at a health conference that it’s more likely a vaccine will be ready by “the end of the year.”

White House coronavirus advisor Dr. Anthony Fauci said Tuesday a coronavirus vaccine probably won’t be ready by the U.S. presidential election even as the Centers for Disease and Prevention asks states to ready distribution facilities by Nov. 1.

At a health conference, Fauci said it’s more likely a vaccine will be ready by “the end of the year” as drug companies Moderna and Pfizer race to complete patient enrollment for their late-stage vaccine trials by the end of September.

“It’s unlikely we’ll have a definitive answer” by the Nov. 3 election, the director of the National Institute of Allergy and Infectious Diseases said at the Research! America 2020 National Health Research Forum.

https://www.cnbc.com

Scientists Cast Doubt on Results From Russian Covid Vaccine

13 hrs ago - (Bloomberg) -- A group of international scientists questioned results from a study of Russia’s fast-moving coronavirus vaccine that were published in the Lancet medical journal, saying some of the findings appeared improbable.

The researchers flagged concerns over seemingly identical levels of antibodies in a number of study participants who were inoculated with the experimental vaccine. This and other patterns in the data present “several different points of concern,” according to an open letter written by Temple University professor Enrico Bucci and signed by more than a dozen other scientists.

The Lancet published results of the early-stage trial last week, offering the first look at the Russian study to be vetted by outside experts. A move by the government to approve the shot for use based on the initial results had drawn widespread skepticism, since vaccines aren’t normally cleared before broad assessments of their efficacy and safety.

The Lancet said it encourages debate on papers that it’s published. “We have shared the letter directly with the authors and encouraged them to engage in the scientific discussion,” the journal said in a statement...

https://www.msn.com

RELATED ARTICLES